Literature DB >> 9721427

Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus.

M Oellerich1, V W Armstrong, E Schütz, L M Shaw.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9721427     DOI: 10.1016/s0009-9120(98)00049-6

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


× No keyword cloud information.
  16 in total

1.  Multisite analytical evaluation of the Abbott ARCHITECT cyclosporine assay.

Authors:  Pierre Wallemacq; Gregory T Maine; Keith Berg; Thomas Rosiere; Pierre Marquet; Giuseppe Aimo; Giulio Mengozzi; Julianna Young; Kurt Wonigeit; Robert Kretschmer; Bendicht Wermuth; Rainer W Schmid
Journal:  Ther Drug Monit       Date:  2010-04       Impact factor: 3.681

Review 2.  Chronopharmacokinetics of ciclosporin and tacrolimus.

Authors:  Massimo Baraldo; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 3.  Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients.

Authors:  P E Wallemacq; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

4.  Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms.

Authors:  G J Dusting; K Akita; H Hickey; M Smith; V Gurevich
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

5.  Cyclosporin therapeutic drug monitoring--an established service revisited.

Authors:  Raymond G Morris
Journal:  Clin Biochem Rev       Date:  2003-05

Review 6.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

7.  Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS.

Authors:  Touraj Shokati; Nicholas Bodenberger; Holly Gadpaille; Björn Schniedewind; Alexander A Vinks; Wenlei Jiang; Rita R Alloway; Uwe Christians
Journal:  J Vis Exp       Date:  2015-11-08       Impact factor: 1.355

8.  Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids.

Authors:  Dennis A Hesselink; Hien Ngyuen; Marike Wabbijn; Peter J H Smak Gregoor; Ewout W Steyerberg; Iza C van Riemsdijk; Willem Weimar; Teun van Gelder
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

Review 9.  Mechanisms of clinically relevant drug interactions associated with tacrolimus.

Authors:  Uwe Christians; Wolfgang Jacobsen; Leslie Z Benet; Alfonso Lampen
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

10.  Topical tacrolimus nanocapsules eye drops for therapeutic effect enhancement in both anterior and posterior ocular inflammation models.

Authors:  Leslie Rebibo; Connie Tam; Yan Sun; Eve Shoshani; Amit Badihi; Taher Nassar; Simon Benita
Journal:  J Control Release       Date:  2021-03-30       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.